Helius Medical Technologies Inc (HSDT)
2.87
+0.21
(+7.89%)
USD |
NASDAQ |
May 03, 16:00
2.71
-0.16
(-5.57%)
After-Hours: 20:00
Helius Medical Technologies Free Cash Flow (Quarterly): -2.037M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -2.037M |
September 30, 2023 | -2.458M |
June 30, 2023 | -2.741M |
March 31, 2023 | -3.209M |
December 31, 2022 | -2.141M |
September 30, 2022 | -3.828M |
June 30, 2022 | -3.674M |
March 31, 2022 | -4.684M |
December 31, 2021 | -3.468M |
September 30, 2021 | -3.265M |
June 30, 2021 | -3.769M |
March 31, 2021 | -2.942M |
December 31, 2020 | -2.22M |
September 30, 2020 | -2.599M |
June 30, 2020 | -3.228M |
March 31, 2020 | -3.761M |
December 31, 2019 | -4.632M |
September 30, 2019 | -5.302M |
June 30, 2019 | -4.457M |
March 31, 2019 | -6.961M |
December 31, 2018 | -5.16M |
Date | Value |
---|---|
September 30, 2018 | -3.574M |
June 30, 2018 | -6.44M |
March 31, 2018 | -4.887M |
December 31, 2017 | -5.095M |
September 30, 2017 | -5.009M |
June 30, 2017 | -6.547M |
March 31, 2017 | -2.864M |
September 30, 2016 | -1.724M |
June 30, 2016 | -2.369M |
March 31, 2016 | -1.683M |
December 31, 2015 | -2.861M |
September 30, 2015 | -1.248M |
June 30, 2015 | -2.146M |
March 31, 2015 | -1.941M |
December 31, 2014 | -1.621M |
September 30, 2014 | -2.218M |
June 30, 2014 | -0.5409M |
March 31, 2014 | -0.3217M |
December 31, 2013 | -0.0099M |
September 30, 2013 | -0.017M |
June 30, 2013 | 0.00 |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.302M
Minimum
Sep 2019
-2.037M
Maximum
Dec 2023
-3.390M
Average
-3.265M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
ARCA biopharma Inc | -1.528M |
Cerus Corp | -15.18M |
NeuroOne Medical Technologies Corp | -3.846M |
Perspective Therapeutics Inc | -9.097M |
Electromed Inc | 3.384M |